Related Experiment Videos
Ibogaine possesses a selective affinity for sigma 2 receptors
R H Mach1, C R Smith, S R Childers
1Department of Radiology, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, NC 27157, USA.
Life Sciences
|January 1, 1995
Summary
The alkaloid ibogaine shows high affinity for sigma 2 receptors, suggesting a potential mechanism for reducing drug craving. Further research into sigma 2-selective ligands is warranted.
Area of Science:
- Neuroscience
- Pharmacology
- Medicinal Chemistry
Background:
- The alkaloid ibogaine is investigated for its potential to reduce drug craving.
- The precise mechanism of action for ibogaine remains largely unknown.
- Understanding ibogaine's receptor interactions is crucial for therapeutic development.
Purpose of the Study:
- To determine the in vitro affinity of ibogaine for sigma 1 and sigma 2 receptors.
- To elucidate the potential role of sigma receptors in ibogaine's anti-addiction effects.
Main Methods:
- In vitro radioligand binding assays were performed.
- The binding affinity (Ki values) of ibogaine for sigma 1 and sigma 2 receptors was quantified.
Main Results:
- Ibogaine demonstrated a high affinity for sigma 2 receptors (Ki = 90.4 and 250 nM).
- Ibogaine exhibited a significantly lower affinity for sigma 1 receptors (Ki = 9310 nM).
- Ibogaine's affinity for sigma 2 receptors may exceed that for other known CNS receptors.
Conclusions:
- Ibogaine's high affinity for sigma 2 receptors suggests a potential therapeutic mechanism.
- The low affinity for sigma 1 receptors indicates ibogaine's potential as a lead compound for sigma 2-selective ligands.
- Further structure-activity relationship studies are recommended for developing novel sigma 2-targeting compounds.